Abstract: Background: Heparanase is an enzyme that cleaves heparan sulfate chains. Oligosaccharides generated by heparanase induce tumor progression. Basal cell carcinoma and squamous cell carcinoma comprise types of nonmelanoma skin cancer. oBjectives: Evaluate the glycosaminoglycans profile and expression of heparanase in two human cell lines established in culture, immortalized skin keratinocyte (HaCaT) and squamous cell carcinoma (A431) and also investigate the expression of heparanase in basal cell carcinoma, squamous cell carcinoma and eyelid skin of individuals not affected by the disease (control). Methods: Glycosaminoglycans were quantified by electrophoresis and indirect ELISA method. The heparanase expression was analyzed by quantitative RT-PCR (qRTPCR). results: The A431 strain showed significant increase in the sulfated glycosaminoglycans, increased heparanase expression and decreased hyaluronic acid, comparing to the HaCaT lineage. The mRNA expression of heparanase was significantly higher in Basal cell carcinoma and squamous cell carcinoma compared with control skin samples. It was also observed increased heparanase expression in squamous cell carcinoma compared to the Basal cell carcinoma. conclusion: The glycosaminoglycans profile, as well as heparanase expression are different between HaCaT and A431 cell lines. The increased expression of heparanase in Basal cell carcinoma and squamous cell carcinoma suggests that this enzyme could be a marker for the diagnosis of such types of non-melanoma cancers, and may be useful as a target molecule for future alternative treatment.
INTRODUCTION
According to data from the National Cancer Institute (INCA), nonmelanoma skin cancer is the most common cancer in Brazil. It corresponds to 33% of all malignant tumors in the country, and presents low mortality and high cure rates when detected early on. Of the types of nonmelanoma skin cancer, basal cell carcinoma (BCC) is the most common, responsible for 70% of the diagnoses, while squamous cell carcinoma (SCC), is responsible for approximately 25% of the cases. These tumors present differences in behavior, growth, and metastatic capacity. 1 Both BCC and SCC present good prognoses, especially if detected in their initial stages. 2 The BCC consisting of cells that resemble epidermal basal cells is the least aggressive of the types of skin cancer. 3 BCC is a tumor with a low degree of malignancy, with the capability of local invasion, tissue destruction, recurrence, and a limited potential of metastasis. 4 BCC is formed by the atypical proliferation of squamous cells, of an invader nature, which can provoke metastasis. 5 SCC presents a considerable potential for recurrence, which is associated with the size of the tumor, degree of histological differentiation, depth of the lesion, perineural invasion, state of the patient's immune system, and anatomic detection. 6 Individuals that develop BCC present a high risk of developing new foci of basal carcinomas, as well as other types of skin cancer, such as melanomas and SCCs. 7 Exposure to ultraviolet radiation is the main risk factor associated with the genesis of BCC and SCC, which is evident due to its greater occurrence when exposed to sunlight. 8 Studies suggest that the exposure to chronic UVB radiation activates heparanase, leading to the degradation of the heparin sulfate in the basal membrane and the increase in the interaction between the growth factor of the epidermis and the dermis. 9 The skin itself contains a large quantity of hyaluronic acid (HA), dermatan sulfate (DS), heparan sulfate (HS), and keratan sulfate (KS), which modulate adhesion, migration, and cell proliferation processes. [10] [11] [12] The sulfated glycosaminoglycan include chondroitin sulfate (CS), DS, KS, heparin (HEP), and HS, while the hyaluronic acid represents a non-sulfate GAG class. 13 The GAG can interact with distinct proteins, including chemokines, cytokines, growth factors, enzymes, and adhesion molecules, promoting the regulation of diverse biological functions. [10] [11] [12] [13] [14] Proteoglycans are macromolecules made up of a protein skeleton linked to GAG strains. Proteoglycans are present on the cell's surface, intracellular granules, and the extracellular matrix, which can regulate cytokines, angiogenic factors, and growth fac- 
Cell strains
This study used cell strains from human keratinocytes (HaCaT) and human SCC cells (A431). The strains defined as HaCaT and A431 were cultivated in a DMEM sterile culture medium, containing 10% bovine fetal serum (FBS) and antibiotics (100 µg/mL of streptmicin and 100 Ul/mL of penicillin).
Enzymatic degradation
The defining of galactosaminoglycans (CS and DS) was ob- 
HA dose
The fluorimetric method was applied to determine the HA described by Martins et al. 21 The quantification of HA from each sample was determined in values expressed by the µg of HA / µg of total proteins. 
Statistical Analysis
The statistical analysis was performed using the Prism5 program for Windows (GraphPad Prism ® Software Inc., CA, USA).
All variables were considered to be non-parametric, in accordance with the Kolmogorov-Smirnov test. When comparing the two groups, the Mann-Whitney test was applied, and to compare more than two groups, the Kruskal Wallis test was applied, followed by the Dunn post-hoc test. For the analyses, the quantitative variables were described by average and standard deviation, while the significance level was set as p <0.05. 
RESULTS

This
DISCUSSION
The GAG sulfates play an important role in cell signaling and in the remodeling of the extracellular matrix. According to the cell type, there is a broad structural variability of GAG sulfates.
Changes in the profile of GAG sulfates are related to the development of many illnesses, such as cancer, inflammatory diseases, degenerative diseases, as well as healing processes. [22] [23] [24] [25] The study of extracellular components, such as proteoglycans, fibrous proteins, glycoproteins, metalloproteases, and glycosidases, can shed light on the molecular changes directly related to the development of such diseases. 16, 24, 26 The results found in the present study characterize the profile of GAG sulfates in HaCaT and A431 cell strains, and demonstrate the increase in HS and DS expressions in cell strains from SCC, as compared to those from keratinocytes, corroborating with data from prior literature, which show changes in such compounds during the development of cancer.
Curiously enough, prior literature has reported that the reduction of HA in biopsy samples from patients diagnosed with SCC is directly related to an unfavorable diagnosis of the disease, in turn suggesting that the reduction of HA immunomarkers presents a direct correlation with patients' lower survival rate. 27 The reduction in the quantity of HA from cell fractions in Tumor progression involves the degradation of extracellular matrix components, which clearly require the action of proteases and glycosidases. 28 The silencing of HPSE, using interference RNA (siRNA), demonstrated a significant reduction in the process of tumor metastasis and angiogenesis, indicating that such an enzyme is essential in the progress of molecular mechanisms of cancer development. Therefore, HPSE has become a potential target for antitumor therapy. 29 Many reports in the literature prove that high levels of HPSE expression in mammal cells seem to be associated with the development of tumors and metastasis. 30, 31 The results obtained in the present study provide evidence that the levels of mRNA from the HPSE enzyme are increased in SCC, as compared to BCC, while non-neoplasic skin suggest a possible correlation of HPSE expression with skin cancer, which corroborates with that reported in prior literature. 18 Treatment with HPSE inhibitors significantly reduces the incidence of tumor metastasis in trials that use the animal model, presenting high levels in advanced stages of the disease.
32,33
The present study also found an expressive HPSE increase in BCC and SCC tumors, when compared to non-neoplasic tissues.
These results demonstrate that the mRNA expression of the HPSE enzyme is significantly higher in nonmelanoma skin cancer. Such results contributed to the findings relative to HPSE expression in the A431 strain, which represents a cell strain formed in SCC.
According to the literature, the main cause of nonmelanoma skin cancer is one's exposure to ultraviolet radiation. Iriyama et al. reported that chronic exposure to UVB radiation activates the HPSE expression, in turn leading to the cleavage of the basal membrane's HS, resulting in changes in the epidermis and dermis of the skin that has been exposed to acute and chronic UVB radiation. 9 Kurdykowski et al. reported that mRNA expression and the enzymatic activity of HPSE were augmented depending on the dose of radiation used in studies with human keratinocyte cell cultures. 34 The significant increase in HS in the A431 tumor strain may well suggest that such a compound can induce HPSE expression, since HS is a substrate of this enzyme, which will trigger the remodeling of the extracellular matrix in tumor tissues and will participate in carcinogenesis.
Prior literature defends that HPSE is involved in tumor angiogenesis and metastasis, suggesting that this enzyme is a promising target for the development of new therapies against nonmelanoma skin cancer. Future studies are warranted to elucidate the mechanisms of cell signaling involved in the increase of the HPSE enzyme expression in the development of BCC and SCC. q
